CLIN Single Use Kit and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of CLIN Single Use Kit and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: clindamycin
Brand name: Cleocin HCl, Cleocin Pediatric, Cleocin Phosphate, Cleocin Phosphate ADD-Vantage, Clindesse, ClindaMax Vaginal, Cleocin
Synonyms: Clindamycin, Clindamycin (Systemic)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- CLIN Single Use Kit-Insulin glargine, recombinant Subcutaneous
- CLIN Single Use Kit-Insulin glulisine
- CLIN Single Use Kit-Insulin Glulisine (Cartridges and Pens)
- CLIN Single Use Kit-Insulin Glulisine (Vials)
- CLIN Single Use Kit-Insulin glulisine Subcutaneous
- CLIN Single Use Kit-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Clinac BPO 7
- Insulin glargine and lixisenatide Subcutaneous-Clinacort
- Insulin glargine and lixisenatide Subcutaneous-Clinda-Derm
- Insulin glargine and lixisenatide Subcutaneous-Clinda-Derm Topical
- Insulin glargine and lixisenatide Subcutaneous-Clindacin ETZ
- Insulin glargine and lixisenatide Subcutaneous-Clindacin ETZ Topical